Nike (NKE) PT Lowered to $92 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St muted after Fed Chair Warsh's speech; AI rally cools
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil drifts lower as Hormuz flows balance slow progress in Iran diplomacy
- Dollar climbs after Warsh comments, poised for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- BioNTech ends colorectal cancer mRNA therapy trial early
Argus Reiterates Hold Rating on Nike (NKE)
July 1, 2024 1:10 PM EDTArgus analyst John Staszak reiterated a Hold rating on Nike (NYSE: NKE).
The analyst comments " Weakening demand We remain concerned about Nikes $7.5 billion in inventory. The company will need to cut prices to clear this inventory, which will weigh on margins and earnings in... More
Nike (NKE) PT cut to $89 at CFRA (correction)
June 28, 2024 9:33 AM EDT(Updated - June 29, 2024 6:18 AM EDT)
CFRA analyst Zachary Warring cut the price target on Nike (NYSE: NKE) to $89.00 (from $95.00) while maintaining a Hold rating.
The analyst comments "We lower our 12-month price target by $6 to $89, based on 25.5x our FY 25 (May) EPS... More
Nike (NKE) PT Lowered to $100 at Telsey
June 28, 2024 7:22 AM EDTTelsey analyst Christina Fernandez lowered the price target on Nike (NYSE: NKE) to $100.00 (from $115.00) while maintaining a Outperform rating.
The analyst comments "Nikes 4QF24 result and lowered FY25 sales guidance is disappointing and reflects a broader slowdown in demand for Nike products, now spanning more heavily into the lifestyle footwear business, and steeper reductions in the supply of its three largest lifestyle franchisesAir Force 1, Air Jordan 1, and Dunkto preserve their long-term health. Nike... More

